Search clinical trials for: Citalopram 40mg

Total 2711 results

University of Texas Southwestern Medical Center
Forest Laboratories

Completed

Treatment of Outpatients With Severe Asthma and Moderate or Severe Major Depressive Disorder

Severe Asthma | Moderate or Severe Major Depressive Disorder

United States
University of Washington
National Institutes of Health (NIH); Forest Laboratories

Terminated

Sinusitis and Facial Pain Disorders Anti-Depression Trial (SFPAT)

Depression | Chronic Sinusitis | Facial Pain Disorder

United States
Kiyuk Chang, MD,PhD

Recruiting

Low Dose Rosuvastatin Plus Ezetimibe Versus High-dose Rosuvastatin in AMI (ROSUZET-AMI)

Myocardial Infarction | Statin Adverse Reaction | HMG-CoA Reductase Inhibitor Toxicity

Korea, Republic of
GlaxoSmithKline

Completed

A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Administering Multiple Oral Doses of GSK1292263 Alone and With Atorvastatin

Dyslipidemias | Dyslipidaemias

United States
HK inno.N Corporation

Completed

Food-Effect on PK and PD of Single Oral Dose of Tegoprazan in Healthy Male Subjects

Healthy

Korea, Republic of
University of California, San Diego

Recruiting

Guselkumab (Anti-IL 23 Monoclonal Antibody) for Alcohol Associated Liver Disease

Alcoholic Liver Disease

United States
HK inno.N Corporation

Completed

Study to Confirm the Safety and Efficacy of Tegoprazan in Patients With Healed Erosive Reflux Disease

Erosive Reflux Disease

Korea, Republic of
Huashan Hospital
Seattle Integrative Cancer Center

Unknown

Metronomic Chemotherapy in Advanced Gastric Cancer

Metastatic Gastric Cancer | Locally Advanced Gastric Cancer

China, United States
Yungjin Pharm. Co., Ltd.
Seoul National University Hospital

Completed

A Study to Compare the Safety, Pharmacokinetics and Pharmacodynamics of YPI 011 to Rabeprazole in Healthy Adult Subjects

Gastroesophageal Reflux Disease

Korea, Republic of
University Hospital Bispebjerg and Frederiksberg

Completed

Effects of Single Dose Citalopram and Reboxetine on Urethral and Anal Closure Function on Healthy Female Subjects

Stress Urinary Incontinence | Fecal Incontinence

Denmark
New York State Psychiatric Institute

Completed

Developing New Clinical Management Strategies

Major Depressive Disorder

United States
Chinese University of Hong Kong

Completed

SSRI Study for Functional Dyspepsia (SS)

Depression | Dyspepsia | Anxiety

Hong Kong
Weill Medical College of Cornell University
Forest Laboratories

Terminated

Lexapro for Major Depression in Patients With Epilepsy

Epilepsy | Major Depression

United States
Duke University
St. Louis University

Completed

Escitalopram Treatment of Night Eating Syndrome

Night Eating Syndrome

United States
Tel-Aviv Sourasky Medical Center

Unknown

The Effect of Escitalopram on Mood, Quality of Life and Cognitive Functioning in Glioblastoma Patients (Cipralex&GBM)

Depression | GBM

Israel
Duke University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Responses of Myocardial Ischemia to Escitalopram Treatment (REMIT)

Myocardial Ischemia

United States
Xian-Janssen Pharmaceutical Ltd.

Completed

A Safety and Efficacy Study of Escitalopram on Acute Treatment of Severe Depression

Major Depressive Disorder

China
University of Aarhus
Aarhus University Hospital

Withdrawn

Escitalopram Treatment In Acute Stroke (ESTIAS)

Stroke

Denmark
Hopital Jean Minjoz
H. Lundbeck A/S

Completed

MOTIV Study- Effect of Antidepressive Treatment by Escitalopram in Patients Undergoing Coronary Artery Bypass Grafting

Coronary Artery Disease

France
Forest Laboratories

Completed

Study of Escitalopram in Adult Patients With Major Depressive Disorder

Major Depressive Disorder

United States
BC Women's Hospital & Health Centre

Completed

Escitalopram in the Treatment of Postpartum Depression

Postpartum Depression

Canada
Conrad, Erich J., M.D.
Forest Laboratories

Completed

Escitalopram Treatment of Major Depression in Patients With Temporal Lobe Epilepsy

Major Depression | Temporal Lobe Epilepsy

United States
Sanofi

Completed

A Trial Evaluating the Efficacy and Tolerability of SSR125543 in Outpatients With Major Depressive Disorder (AGATE)

Major Depression

Belgium, Canada, Chile, Estonia, Finland, France, Germany, Netherlands, Russian Federation, Slovakia, South Africa, Sweden
Northern California Institute of Research and Education

Completed

Open Trial of Escitalopram Treatment for Male Subjects With Posttraumatic Stress Disorder

Chronic Posttraumatic Stress Disorder
Nordfjord Psychiatric Centre
H. Lundbeck A/S

Terminated

Escitalopram in Bipolar Depression: a Placebo-controlled Study of Acute and Maintenance Treatment

Bipolar Disorder

Norway
Tri-Service General Hospital

Completed

Wearable Devices to Assess Effects of Central Nervous Medications on Physical Conditions in Patients With Sleep Problems

Anxiety Disorders | Sleep Apnea

Taiwan
Kunming Medical University
Chinese Academy of Sciences

Completed

A Neuroimaging and Epigenetic Investigation of Antidepressants in Depression

Depression | Depression Secondary to Other Disease

China
VA Nebraska Western Iowa Health Care System
Forest Laboratories

Completed

Effects of Escitalopram on Autonomic Reactivity in Post Traumatic Stress Disorder

PTSD

United States
Weill Medical College of Cornell University
National Institute of Mental Health (NIMH); Forest Laboratories

Completed

Treatment Response of Geriatric Depression (ERP)

Depression

United States
Washington University School of Medicine
National Institute of Mental Health (NIMH)

Completed

fMRI Studies of Emotional Brain Circuitry in People With Major Depression

Depression
Xian-Janssen Pharmaceutical Ltd.

Completed

An Efficacy and Safety Study of Escitalopram Long-Term Treatment in Major Depressive Disorder With Associated Anxiety Symptoms (Lexapro)

Depressive Disorder, Major

China
Weill Medical College of Cornell University
National Institute of Mental Health (NIMH); Forest Laboratories

Completed

Aging Brain Changes, Executive Dysfunction and Depression (FA)

Depression
Weill Medical College of Cornell University

Completed

Assessing Anterior Cingulate Brain Activity in People With Late-Life Depression

Depression

United States
Massachusetts General Hospital
Forest Laboratories

Completed

Influence of Escitalopram on Fear Conditioning

Fear Conditioning
University of California, Los Angeles
National Institute of Mental Health (NIMH)

Completed

Biomarkers for Outcomes In Late-life Depression (BOLD) (BOLD)

Major Depressive Disorder

United States
Seoul National University Hospital

Unknown

Neuroprotective/Neurotrophic Effect of Lexapro® in Patients With Posttraumatic Stress Disorder

Posttraumatic Stress Disorder

Korea, Republic of
Beitou Armed Forces Hospital, Taipei, Taiwan

Unknown

The Effects of Escitalopram on Cytokines (BAFH)

Depression

Taiwan
Pharmacology Research Institute

Unknown

Escitalopram Combination Comparison Study for Adult Patients With Major Depressive Disorder

Major Depressive Disorder

United States
Charite University, Berlin, Germany
H. Lundbeck A/S

Completed

Investigation of a Combination Treatment of Escitalopram and rTMS

Major Depressive Disorder

Germany
Community Pharmacology Services Ltd

Completed

Efficacy and Safety of Escitalopram Doses up to 50mg in Treatment of MDD

Major Depressive Disorder

United Kingdom
Tel-Aviv Sourasky Medical Center

Unknown

The Effect of Selective Serotonin Reuptake Inhibitor (SSRI) Treatment on Affective Symptoms and Fertility Treatment Outcome in Women Undergoing in Vitro Fertilization (IVF)

Depression | Anxiety | In Vitro Fertilization

Israel
Gustave Roussy, Cancer Campus, Grand Paris

Unknown

Double-blind, Placebo-controlled, Randomized Study of the Effectiveness of Escitalopram on Emotional Distress of Head and Neck Cancer Patients During Cancer Treatment

Carcinomas

France
Massachusetts General Hospital
Forest Laboratories

Completed

Escitalopram for the Treatment of Self-Injurious Skin Picking

Impulse Control Disorders

United States
Forest Laboratories

Completed

Fixed Dose Comparison of Escitalopram to an Active Comparator in Severely Depressed Patients

Major Depressive Disorder

United States
BeerYaakov Mental Health Center
Lundbeck Israel

Completed

The Efficacy of Escitalopram for Negative Symptoms in Schizophrenia

Schizophrenia

Israel
Massachusetts General Hospital
Forest Laboratories

Completed

Escitalopram for the Treatment of Obsessive Compulsive Disorder (OCD)

Obsessive Compulsive Disorder

United States
Psychiatric Hospital, Hillerod
Amager Hospital; Psychiatric Center Ballerup; Psychogeriatric Unit, CU Hospital... and other collaborators

Terminated

Treatment of Depression in the Elderly

Depression

Denmark
Hospital Regional 1o de Octubre
Universidad Nacional Autonoma de Mexico; National Polytechnic Institute, Mexico

Completed

Comparison of Fluoxetine Versus Citalopram Therapy to Control Postmenopausal Vasomotor Syndrome

Hot Flashes | Postmenopause

Mexico
Fundación Pública Andaluza para la gestión de la...

Terminated

Loss of Response of Adalimumab Biosimilar vs Adalimumab Original, in Inflammatory Bowel Disease. (ADA-SWITCH)

Crohn Disease | Ulcerative Colitis

Spain
Shirley Ryan AbilityLab
Rady Children's Hospital, San Diego

Not yet recruiting

Repurposing 5-Azacytidine for the Treatment of Muscle Contractures in Children With Cerebral Palsy

Cerebral Palsy | Contracture

Search clinical trials for: Citalopram 40mg

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Suriname

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations